Access cutting-edge rsv treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access rsv specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rsv treatment provided free
This study aims to check how safe and well-tolerated a second dose of RSVpreF is when given during later pregnancies, and to see how long the immunity lasts from a single dose given during a previous pregnancy by examining the blood of nonpregnant participants who had the vaccine before.
Sponsor: Pfizer
Check if you qualify for this rsv clinical trial in Los Angeles, CA
If you're searching for rsv treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rsv specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.